[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100634109":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":20,"locations":20,"responsibleParty":21,"collaborators":20,"id":25,"slug":26,"hasResults":27,"nctId":28,"briefTitle":29,"officialTitle":29,"acronym":20,"eligibilityCriteria":30,"healthyVolunteers":31,"sex":32,"minAge":33,"maxAge":34,"enrollmentInfo":35,"targetDuration":20,"studyType":38,"phases":39,"briefSummary":41,"conditions":42,"keywords":44,"overallStatus":48,"whyStopped":20,"lastUpdateSubmitDate":49,"lastUpdatePostDateStruct":50,"startDateStruct":53,"completionDateStruct":55,"leadSponsor":57,"locationsCount":20},{"fullName":5,"class":6},"Massachusetts General Hospital","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Liposomal Bupivacaine Arm","EXPERIMENTAL","Participants undergoing interventional radiology procedures will receive liposomal bupivacaine administered via local infiltration at the procedural site as part of peri-procedural pain management. The intervention will be performed using standard dosing and technique at the discretion of the treating physician. Pain scores and analgesic requirements will be collected following the procedure to assess outcomes.",[13],"Drug: Liposomal Bupivacaine (EXPAREL®)\u002FBupivacaine",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DRUG","Liposomal Bupivacaine (EXPAREL®)\u002FBupivacaine","Liposomal bupivacaine will be administered via local infiltration at the procedural site to provide analgesia. This formulation consists of bupivacaine encapsulated in liposomes, allowing for slow release of the anesthetic over time and potentially prolonged pain control compared to standard bupivacaine. The medication will be used as part of routine peri-procedural pain management during interventional radiology procedures.",[9],null,{"type":22,"investigatorFullName":23,"investigatorTitle":24,"investigatorAffiliation":5,"oldNameTitle":20,"oldOrganization":20},"PRINCIPAL_INVESTIGATOR","Rafael, Vazquez","Director of Non OR Anesthesiology","100634109","phase-4-bupivacaine-liposome-suspension-administration-to-decreasre-peri-procedural-pain-in-interventional-radiology-ir-procedures-100634109",false,"NCT07535411","Bupivacaine Liposome Suspension Administration to Decreasre Peri-procedural Pain in Interventional Radiology (IR) Procedures","Inclusion Criteria:\n\n\\-\n\nExclusion Criteria:\n\n* chronic pain condition",true,"ALL","18 Years","95 Years",{"count":36,"type":37},10,"ESTIMATED","INTERVENTIONAL",[40],"PHASE4","This study evaluates the use of liposomal bupivacaine (Exparel), a long-acting local anesthetic, for peri-procedural pain control in patients undergoing interventional radiology (IR) procedures. Effective pain management during and after IR procedures is important for patient comfort, procedural success, and recovery, yet standard local anesthetics (e.g., lidocaine or bupivacaine HCl) provide relatively short durations of analgesia.\n\nLiposomal bupivacaine is an FDA-approved formulation designed to provide extended-release local anesthetic effects over a prolonged period. Its use has been studied in surgical settings, but data in interventional radiology procedures remain limited. This prospective, single-arm quality improvement initiative aims to assess whether incorporation of liposomal bupivacaine into routine procedural care improves patient-reported pain outcomes.\n\nAdult patients undergoing IR procedures will receive liposomal bupivacaine administered by the proceduralist as part of standard care. Pain will be assessed using a structured patient-reported outcome survey at multiple time points, including pre-procedure, during the procedure, 1 hour post-procedure, and within 24 hours post-procedure. The survey also captures use of additional analgesic medications within the first 24 hours.\n\nThe primary outcome is patient-reported pain intensity. Secondary outcomes include post-procedural analgesic utilization. Data will be analyzed descriptively given the exploratory nature and small sample size.\n\nFindings from this project may inform future approaches to pain management in interventional radiology and help determine whether longer-acting local anesthetics provide clinically meaningful improvements in patient experience.",[43],"Analgesia Assessment",[45,46,47],"Liposomal Bupivicaine","Exparel","Local Anesthesia","NOT_YET_RECRUITING","2026-04-10",{"date":51,"type":52},"2026-04-17","ACTUAL",{"date":54,"type":37},"2026-05",{"date":56,"type":37},"2026-07",{"name":5,"class":6}]